Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10594585 | Bioorganic & Medicinal Chemistry Letters | 2012 | 8 Pages |
Abstract
A series of potent antagonists of the ion channel transient receptor potential A1 (TRPA1) was developed by modifying lead structure 16 that was discovered by high-throughput screening. Based on lead compound 16, a SAR was established, showing a narrow region at the nitro-aromatic R1 moiety and at the warhead, while the R2 side had a much wider scope including ureas and carbamates. Compound 16 inhibits Ca2+-activated TRPA1 currents reversibly in whole cell patch clamp experiments, indicating that under in vivo conditions, it does not react covalently, despite its potentially electrophilic ketone.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Karl S.A. Vallin, Karin J. Sterky, Eva Nyman, Jenny Bernström, Rebecka From, Christian Linde, Alexander B.E. Minidis, Andreas Nolting, Katja Närhi, Ellen M. Santangelo, Fernando W. Sehgelmeble, Daniel Sohn, Jennie Strindlund, Dirk Weigelt,